Acquisition (Tables)

12 Months Ended

Dec. 31, 2014

Business Combinations [Abstract]

Schedule of Assets Acquired and Liabilities Assumed

The table below summarizes the final allocation of the purchase price based upon the fair values of assets acquired and liabilities assumed at the Acquisition Date.

	(in thousands)
Cash and cash equivalents	$	3,056
Accounts receivable – billed		447
Prepaid expenses and other assets		1,092
Property and equipment		165
Intangible assets		16,620
Goodwill		25,424
Accounts payable and other current liabilities		(2,994)
Capital leases		(94)
Notes payable		(193)
Other non-current liabilities		(1,559)
Total purchase price	$	41,964

Unaudited Pro Forma Financial Information of Operations

The unaudited pro forma financial information combines the historical results of operations of Novavax and Isconova AB for the periods presented below:

	Year Ended
	December 31,
	2013		2012
	(in thousands)
Revenue	$	22,785	$	24,810
Net loss	$	(55,594)	$	(35,042)
Basic and diluted net loss per share	$	(0.31)	$	(0.24)